J F Ludvigsson1, U de Faire, A Ekbom, S M Montgomery. 1. Clinical Epidemiology Unit, Department of Medicine, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden. jonasludvigsson@yahoo.com
Abstract
OBJECTIVES: To evaluate the risk of cardiovascular disease in individuals with coeliac disease (CD). DESIGN: Swedish national hospital-based register data were used to identify 13,358 individuals who had been diagnosed with CD (1964-2003) and 64,118 age-matched and sex-matched individuals without CD. Cox regression was used to estimate the risk of vascular disease in subjects with CD. Analyses were restricted to individuals with a follow-up of >1 year and with no vascular disease before study entry. RESULTS: CD was associated with myocardial infarction (HR 1.27; 95% CI 1.09 to 1.48), angina pectoris (1.46; 1.25 to 1.70), heart failure (1.41; 1.22 to 1.62), brain haemorrhage (1.40; 1.05 to 1.88) and ischaemic stroke (1.35; 1.14 to 1.60). These risk estimates were similar when analyses were restricted to adults in whom vascular disease had been listed as the main diagnosis. In post-hoc analyses, where reference individuals were restricted to inpatients, no association was found between CD and later vascular disease, except for a lower risk of heart failure (0.79; 0.68 to 0.92). CONCLUSIONS: The positive association between CD and later vascular disease may be explained by ascertainment bias.
OBJECTIVES: To evaluate the risk of cardiovascular disease in individuals with coeliac disease (CD). DESIGN: Swedish national hospital-based register data were used to identify 13,358 individuals who had been diagnosed with CD (1964-2003) and 64,118 age-matched and sex-matched individuals without CD. Cox regression was used to estimate the risk of vascular disease in subjects with CD. Analyses were restricted to individuals with a follow-up of >1 year and with no vascular disease before study entry. RESULTS: CD was associated with myocardial infarction (HR 1.27; 95% CI 1.09 to 1.48), angina pectoris (1.46; 1.25 to 1.70), heart failure (1.41; 1.22 to 1.62), brain haemorrhage (1.40; 1.05 to 1.88) and ischaemic stroke (1.35; 1.14 to 1.60). These risk estimates were similar when analyses were restricted to adults in whom vascular disease had been listed as the main diagnosis. In post-hoc analyses, where reference individuals were restricted to inpatients, no association was found between CD and later vascular disease, except for a lower risk of heart failure (0.79; 0.68 to 0.92). CONCLUSIONS: The positive association between CD and later vascular disease may be explained by ascertainment bias.
Authors: Martin Lindström; Mahnaz Moghaddassi; Kristian Bolin; Björn Lindgren; Juan Merlo Journal: Scand J Public Health Date: 2003 Impact factor: 3.021
Authors: Juliano L Fernandes; Ronei L Mamoni; James L Orford; Concilia Garcia; Andrew P Selwyn; Otavio R Coelho; Maria Heloisa S L Blotta Journal: Cytokine Date: 2004-05-07 Impact factor: 3.861
Authors: Markku Mäki; Kirsi Mustalahti; Jorma Kokkonen; Petri Kulmala; Mila Haapalahti; Tuomo Karttunen; Jorma Ilonen; Kaija Laurila; Ingrid Dahlbom; Tony Hansson; Peter Höpfl; Mikael Knip Journal: N Engl J Med Date: 2003-06-19 Impact factor: 91.245
Authors: Antonio Tursi; Walter Elisei; Gian Marco Giorgetti; Giovanni Brandimarte; Fabio Aiello Journal: Dig Dis Sci Date: 2008-12-05 Impact factor: 3.199
Authors: Walter F Tetzlaff; Tomás Meroño; Martin Menafra; Maximiliano Martin; Eliana Botta; Maria D Matoso; Patricia Sorroche; Juan A De Paula; Laura E Boero; Fernando Brites Journal: World J Cardiol Date: 2017-05-26